指南与共识产科母胎医学

未达德尔菲胎儿生长受限共识标准的「小」胎儿不良围产结局风险

Risk of adverse perinatal outcomes in pregnancies with "small" fetuses not meeting Delphi consensus criteria for fetal growth restriction.
指南 / 共识 · Am J Obstet Gynecol · 2023-04-30

基于2010-2022年单中心前瞻性队列的巢式病例对照研究,经倾向评分1:1匹配后分析2186对,比较符合德尔菲胎儿生长受限标准组、未达共识标准的小于胎龄组与适龄对照组;未达共识标准的小于胎龄组不良围产结局比值比为0.62(95%CI 0.39-1.00),符合共识标准的胎儿生长受限组为3.08(95%CI 2.25-4.20)。

要点

  • 未达德尔菲共识标准的小于胎龄胎儿不良围产结局风险未显著升高,OR 0.62(95%CI 0.39-1.00)。
  • 符合德尔菲共识标准的胎儿生长受限不良结局风险升高,OR 3.08(95%CI 2.25-4.20)。
  • 作者认为这些胎儿多数为健康的体质性小胎儿,但仍应密切监测生长以及时发现进展为生长受限。

核心结论

  • 未达德尔菲胎儿生长受限共识标准(基于多普勒波形和/或≥32周的生长速度)、估计胎儿体重和/或腹围位于第3至第9百分位的胎儿,未发现其不良结局风险升高的证据。

研究设计与样本

  • 数据来自2010-2022年单中心学术三级医疗机构的单胎非畸形妊娠被动前瞻性队列,分为符合德尔菲胎儿生长受限标准组、未达共识标准的小于胎龄组和随机选取出生体重第20至第80百分位的适龄对照组。
  • 采用1:1倾向评分匹配的巢式病例对照研究,对3组间混杂因素进行调整;主要结局为复合结局:围产期死亡、5分钟Apgar评分<7、脐带血pH≤7.10或碱剩余≥12。

主要发现

  • 共2866例妊娠符合纳入标准;倾向评分匹配后共2186对匹配,小于胎龄组511例(23%)、适龄对照组1093例(50%)、胎儿生长受限组582例(27%)。
  • 210例妊娠(10%)发生不良围产结局;小于胎龄组和适龄对照组均无围产期死亡。
  • 小于胎龄组511例中23例(5%)因5分钟Apgar评分和/或脐血气结果发生不良结局,适龄对照组1093例中77例(7%),OR 0.62(95%CI 0.39-1.00)。
  • 符合共识标准的胎儿生长受限组582例中110例(19%)发生不良结局,OR 3.08(95%CI 2.25-4.20),包括34例围产期死亡或出院前死亡。
  • 与不良结局风险升高独立相关的因素包括慢性高血压、妊娠期高血压疾病和早发型胎儿生长受限。

关键数值与推荐

  • 在调整预测不良围产结局模型中的其他6个因素后,小于胎龄与主要结局无关联。
  • 预测不良围产结局模型的偏倚校正自助法受试者工作特征曲线下面积为0.72(95%CI 0.66-0.74)。
  • 7因素模型预测不良围产结局的偏倚校正自助法受试者工作特征曲线下面积为0.72(95%CI 0.66-0.74)。

临床怎么用

  • 作者认为这些胎儿多数为健康的体质性小胎儿,但仍应密切监测其生长以排除进展中的生长受限。
  • 作者认为按疑似病理性生长受限相同方式管理这些胎儿可能导致不必要的产前检测,并增加因早产或早期足月分娩低风险小胎儿所致医源性并发症的风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous research endeavors examining the association between clinical characteristics, sonographic indices, and the risk of adverse perinatal outcomes in pregnancies complicated by fetal growth restriction have been hampered by a lack of agreement regarding its definition. In 2016, a consensus definition was reached by an international panel of experts via the Delphi procedure, but as it currently stands, this has not been endorsed by all professional organizations. OBJECTIVE: This study aimed to assess whether an independent association exists between estimated fetal weight and/or abdominal circumference of <10th percentile and adverse perinatal outcomes when consensus criteria for growth restriction are not met. STUDY DESIGN: Data were derived from a passive prospective cohort of singleton nonanomalous pregnancies at a single academic tertiary care institution (2010-2022) that fell into 3 groups: (1) consecutive fetuses that met the Delphi criteria for fetal growth restriction, (2) small-for-gestational-age fetuses that failed to meet the consensus criteria, and (3) fetuses with birthweights of 20th to 80th percentile randomly selected as an appropriately grown (appropriate-for-gestational-age) comparator group. This nested case-control study used 1:1 propensity score matching to adjust for confounders among the 3 groups: fetal growth restriction cases, small-for-gestational-age cases, and controls. Our primary outcome was a composite: perinatal demise, 5-minute Apgar score of <7, cord pH of ≤7.10, or base excess of ≥12. Pregnancy characteristics with a P value of <.2 on univariate analyses were considered for incorporation into a multivariable model along with fetal growth restriction and small-for-gestational-age to evaluate which outcomes were independently predictive of adverse perinatal outcomes. RESULTS: Overall, 2866 pregnancies met the inclusion criteria. After propensity score matching, there were 2186 matched pairs, including 511 (23%), 1093 (50%), and 582 (27%) patients in the small-for-gestational-age, appropriate-for-gestational-age, and fetal growth restriction groups, respectively. Moreover, 210 pregnancies (10%) were complicated by adverse perinatal outcomes. None of the pregnancies with small-for-gestational-age OR appropriate-for-gestational-age fetuses resulted in perinatal demise. Twenty-three of 511 patients (5%) in the small-for-gestational-age group had adverse outcomes based on 5-minute Apgar scores and/or cord gas results compared with 77 of 1093 patients (7%) in the appropriate-for-gestational-age group (odds ratio, 0.62; 95% confidence interval, 0.39-1.00). Furthermore, 110 of 582 patients (19%) with fetal growth restriction that met the consensus criteria had adverse outcomes (odds ratio, 3.08; 95% confidence interval, 2.25-4.20), including 34 patients with perinatal demise or death before discharge. Factors independently associated with increased odds of adverse outcomes included chronic hypertension, hypertensive disorders of pregnancy, and early-onset fetal growth restriction. Small-for-gestational age was not associated with the primary outcome after adjustment for 6 other factors included in a model predicting adverse perinatal outcomes. The bias-corrected bootstrapped area under the receiver operating characteristic curve for the model was 0.72 (95% confidence interval, 0.66-0.74). The bias-corrected bootstrapped area under the receiver operating characteristic curve for a 7-factor model predicting adverse perinatal outcomes was 0.72 (95% confidence interval, 0.66-0.74). CONCLUSION: This study found no evidence that fetuses with an estimated fetal weight and/or abdominal circumference of 3rd to 9th percentile that fail to meet the consensus criteria for fetal growth restriction (based on Doppler waveforms and/or growth velocity of ≥32 weeks) are at increased risk of adverse outcomes. Although the growth of these fetuses should be monitored closely to rule out evolving growth restriction, most cases are healthy constitutionally small fetuses. The management of these fetuses in the same manner as those with suspected pathologic growth restriction may result in unnecessary antenatal testing and increase the risk of iatrogenic complications resulting from preterm or early term delivery of small fetuses that are at relatively low risk of adverse perinatal outcomes.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Powel JE, Chavan NR, Zantow EW, et al. Risk of adverse perinatal outcomes in pregnancies with "small" fetuses not meeting Delphi consensus criteria for fetal growth restriction. Am J Obstet Gynecol. 2023. PMID: 37767605. doi:10.1016/j.ajog.2023.04.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。